Please contact us for further information.
https://www.formosalab.com/
*The following content is generated by AI and is for reference only.
Overview
Imatinib Mesylate is a small-molecule tyrosine kinase inhibitor used primarily in oncology. Manufactured via multi-step organic synthesis, its molecular formula is C29H31N7O·CH4SO3, with CAS No. 152486-40-9.
Application
- Treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).
- Targeted therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
- R&D raw material for pharmaceutical formulation development and clinical trials.
Precautions
Strictly store below 25°C in dry conditions to maintain stability. Handling requires PPE due to potential cytotoxicity; avoid inhalation or skin contact during industrial processing.